This patent covers the use of anti-MHC antibodies to induce "retrodifferentiation" of peripheral blood cells into CD34 hematopoietic stem cells.
If there is even a shred of evidence that the concepts put forth in this patent are real, then the inventors are sitting on a gold mine. However, with exception to publications in very very low impact journals only by the authors of the patent, we have not seen anyone verifying the FANTASTIC claims that this patent is making.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.